Gray matter atrophy in multiple sclerosis despite clinical and lesion stability during natalizumab treatment

BACKGROUND: Brain volume loss is an important surrogate marker for assessing disability in MS; however, contribution of gray and white matter to the whole brain volume loss needs further examination in the context of specific MS treatment. OBJECTIVES: To examine whole and segmented gray, white, thal...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Koskimäki, Fredrika, Bernard, Jacqueline, Yong, Jeong, Arndt, Nancy, Carroll, Timothy, Lee, Seon-Kyu, Reder, Anthony T., Javed, Adil
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6303064/
https://ncbi.nlm.nih.gov/pubmed/30576361
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0209326
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados